HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Photodynamic therapy in von Hippel-Lindau disease in children.

Abstract
Von Hippel-Lindau disease is characterized by retinal hemangiomas that often produce hemorrhages and retinal detachment. A 10-year-old boy with von Hippel-Lindau disease presenting with telangiectasias, endophytic angiomas, and exudative retinal detachment underwent treatment with retrobulbar steroid injection, laser photocoagulation, and photodynamic therapy, which led to improvement of visual acuity.
AuthorsMichele Fortunato, Rossana Di Pietro, Luciano Gravina, Riccardo Maggi, Andrea Ubaldi, Pasquale Vadalà
JournalJournal of pediatric ophthalmology and strabismus (J Pediatr Ophthalmol Strabismus) 2009 Nov-Dec Vol. 46 Issue 6 Pg. 376-9 ISSN: 0191-3913 [Print] United States
PMID19928746 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2009, SLACK Incorporated.
Chemical References
  • Photosensitizing Agents
  • Porphyrins
  • Verteporfin
Topics
  • Child
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Male
  • Ophthalmoscopy
  • Photochemotherapy (methods)
  • Photosensitizing Agents (therapeutic use)
  • Porphyrins (therapeutic use)
  • Retinal Detachment (drug therapy, pathology)
  • Verteporfin
  • Visual Acuity
  • von Hippel-Lindau Disease (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: